Login / Signup

New persistent opioid use among adolescents and young adults with sarcoma.

Melissa P BeaucheminRohit R RaghunathanMelissa K AccordinoJacob C CoganJustine M KahnJason D WrightDawn L Hershman
Published in: Cancer (2022)
Using an insurance claims database, we conducted a study to determine the rate of new persistent opioid use among adolescents and young adults treated for sarcoma. We found that 64% of adolescents and young adults treated for sarcoma received opioid prescriptions during treatment, and 23% of these patients met the criteria for new persistent opioid use. These findings support the need for age-appropriate education and novel pain management strategies in this vulnerable population.
Keyphrases
  • pain management
  • newly diagnosed
  • chronic pain
  • end stage renal disease
  • ejection fraction
  • health insurance
  • chronic kidney disease
  • healthcare
  • peritoneal dialysis
  • prognostic factors
  • emergency department